The potential role of MCP and therapeutic opportunities for Down syndrome are probably connected with PAI-1 which, interestingly, mediates the neuroprotective activity of TGF-β1 against N-methyl-d-aspartate (NMDA) receptor-mediated excitotoxicity. The gene discussed is SERPINE1; the disease is Down syndrome.